For research use only. Not for human or veterinary use.
Research Summary
ARA-290 (Cibinetide / Helix B Surface Peptide) is a synthetic 11-amino acid peptide derived from the helix B domain of erythropoietin (EPO), designed to selectively activate the innate repair receptor (IRR) — a heterocomplex of the EPO receptor and beta-common receptor (CD131) — without stimulating classical erythropoietic pathways. It is investigated in cytoprotective and anti-inflammatory signalling research, with particular interest in JAK2/STAT3 and PI3K/Akt pathway interactions.
Specifications
|
ARA-290 |
| CAS |
1208243-50-8 |
| Molecular Formula |
C₅₁H₈₄N₁₆O₂₁ |
| Molecular Weight |
1,257.3 g/mol |
| Purity |
≥99% HPLC verified |
| Form |
Lyophilised powder |
| Available |
10mg |
Storage & Handling
Store at −20°C, protected from light and moisture. Reconstitute under controlled laboratory conditions using appropriate sterile technique.
Certificate of Analysis
A Certificate of Analysis is available on request for each batch. Contact us to obtain documentation for your records.
Not evaluated by the TGA or any regulatory authority for safety or efficacy in humans or animals.
